|
US6713045B1
(en)
|
1995-06-02 |
2004-03-30 |
Research Corporation Technologies, Inc. |
Targeted magnetic resonance imaging agents for the detection of physiological processes
|
|
US6770261B2
(en)
|
1995-06-02 |
2004-08-03 |
Research Corporation Technologies |
Magnetic resonance imaging agents for the detection of physiological agents
|
|
US5900228A
(en)
|
1996-07-31 |
1999-05-04 |
California Institute Of Technology |
Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
|
|
US6675035B1
(en)
*
|
1997-06-20 |
2004-01-06 |
Imaging Diagnostic Systems, Inc. |
Phantom for optical and magnetic resonance imaging quality control
|
|
JP2001518523A
(ja)
|
1997-10-02 |
2001-10-16 |
エピックス メディカル， インコーポレイテッド |
インターベンショナル療法をモニタリングするためのコントラスト増強型診断的画像化方法
|
|
US6713046B1
(en)
|
1997-10-27 |
2004-03-30 |
Research Corporation Technologies |
Magnetic resonance imaging agents for the delivery of therapeutic agents
|
|
EP1027077B1
(en)
*
|
1997-10-27 |
2003-03-05 |
Research Corporation Technologies, Inc |
Magnetic resonance imaging agents for the delivery of therapeutic agents
|
|
JP4163381B2
(ja)
|
1997-11-17 |
2008-10-08 |
カリフォルニア・インスティテュート・オブ・テクノロジー |
生理学的薬剤の検出のための磁気共鳴造影剤
|
|
IT1297035B1
(it)
*
|
1997-12-30 |
1999-08-03 |
Bracco Spa |
Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
|
|
IT1297034B1
(it)
*
|
1997-12-30 |
1999-08-03 |
Bracco Spa |
Acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
|
|
US6167297A
(en)
*
|
1999-05-05 |
2000-12-26 |
Benaron; David A. |
Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
|
|
US6230586B1
(en)
*
|
1999-05-21 |
2001-05-15 |
Chung-Hsi Chang |
Electric drive device for a bicycle
|
|
CZ2002343A3
(cs)
|
1999-07-29 |
2002-08-14 |
Epix Medical, Inc. |
Cílená multimerní zobrazovací činidla s multilokální vazebnou schopností
|
|
WO2001052906A2
(en)
*
|
2000-01-22 |
2001-07-26 |
Epix Medical, Inc. |
Magnetic resonance imaging using contrast agents prodrugs bioactivated by enzymatic cleavage
|
|
US6656448B1
(en)
*
|
2000-02-15 |
2003-12-02 |
Bristol-Myers Squibb Pharma Company |
Matrix metalloproteinase inhibitors
|
|
US20040146463A1
(en)
*
|
2000-05-04 |
2004-07-29 |
Meade Thomas J. |
Functional MRI agents for cancer imaging
|
|
US6673333B1
(en)
|
2000-05-04 |
2004-01-06 |
Research Corporation Technologies, Inc. |
Functional MRI agents for cancer imaging
|
|
AU2001259575A1
(en)
*
|
2000-05-04 |
2001-11-12 |
Research Corporation Technologies |
Magnetic resonance imaging agents for the delivery of therapeutic agents
|
|
EP1283728A2
(en)
*
|
2000-05-23 |
2003-02-19 |
Amersham Health AS |
Contrast agents
|
|
US6748259B1
(en)
|
2000-06-15 |
2004-06-08 |
Spectros Corporation |
Optical imaging of induced signals in vivo under ambient light conditions
|
|
AU2001276956A1
(en)
|
2000-07-17 |
2002-01-30 |
California Institute Of Technology |
Macrocyclic mri contrast agents
|
|
US7029655B2
(en)
|
2000-10-04 |
2006-04-18 |
California Institute Of Technology |
Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
|
|
US20030004236A1
(en)
*
|
2001-04-20 |
2003-01-02 |
Meade Thomas J. |
Magnetic resonance imaging agents for detection and delivery of therapeutic agents and detection of physiological substances
|
|
US20020197648A1
(en)
*
|
2001-05-02 |
2002-12-26 |
Silva Robin M. |
High throughput screening methods using magnetic resonance imaging agents
|
|
TWI221406B
(en)
|
2001-07-30 |
2004-10-01 |
Epix Medical Inc |
Systems and methods for targeted magnetic resonance imaging of the vascular system
|
|
ES2506142T3
(es)
|
2002-03-01 |
2014-10-13 |
Dyax Corp. |
Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico
|
|
US20050100963A1
(en)
|
2002-03-01 |
2005-05-12 |
Dyax Corporation |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
|
|
US7794693B2
(en)
|
2002-03-01 |
2010-09-14 |
Bracco International B.V. |
Targeting vector-phospholipid conjugates
|
|
US7261876B2
(en)
|
2002-03-01 |
2007-08-28 |
Bracco International Bv |
Multivalent constructs for therapeutic and diagnostic applications
|
|
US8623822B2
(en)
|
2002-03-01 |
2014-01-07 |
Bracco Suisse Sa |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
|
|
US20030198597A1
(en)
*
|
2002-04-22 |
2003-10-23 |
Meade Thomas J. |
Novel macrocyclic activatible magnetic resonance imaging contrast agents
|
|
AU2003251436A1
(en)
*
|
2002-07-22 |
2004-02-09 |
Bracco Imaging S.P.A. |
Procedures of cellular labelling with paramagnetic complexes for mri applications
|
|
US20050163821A1
(en)
*
|
2002-08-02 |
2005-07-28 |
Hsing-Wen Sung |
Drug-eluting Biodegradable Stent and Delivery Means
|
|
US7226577B2
(en)
|
2003-01-13 |
2007-06-05 |
Bracco Imaging, S. P. A. |
Gastrin releasing peptide compounds
|
|
EP2949658B1
(en)
|
2003-03-03 |
2018-08-08 |
Dyax Corp. |
Peptides that specifically bind HGF receptor (cMet) and uses thereof
|
|
AU2004264857B2
(en)
*
|
2003-07-09 |
2010-06-10 |
Sutter West Bay Hospitals |
Remote detection of substance delivery to cells
|
|
US20050106100A1
(en)
*
|
2003-09-03 |
2005-05-19 |
Harris Thomas D. |
Compounds containing matrix metalloproteinase substrates and methods of their use
|
|
US20050124008A1
(en)
*
|
2003-12-05 |
2005-06-09 |
Kauvar Lawrence M. |
Homogeneous competition assays
|
|
NO20035683D0
(no)
*
|
2003-12-18 |
2003-12-18 |
Amersham Health As |
Optisk avbildning av prostatakreft
|
|
FR2868320B1
(fr)
*
|
2004-03-31 |
2007-11-02 |
Centre Nat Rech Scient Cnrse |
Agent de contraste pour l'imagerie par resonance magnetique
|
|
WO2006099332A2
(en)
|
2005-03-11 |
2006-09-21 |
Wake Forest University Health Sciences |
Production of tissue engineered digits and limbs
|
|
US7531503B2
(en)
*
|
2005-03-11 |
2009-05-12 |
Wake Forest University Health Sciences |
Cell scaffold matrices with incorporated therapeutic agents
|
|
US20060204539A1
(en)
|
2005-03-11 |
2006-09-14 |
Anthony Atala |
Electrospun cell matrices
|
|
EP1863546B1
(en)
*
|
2005-03-11 |
2015-10-07 |
Wake Forest University Health Sciences |
Production of tissue engineered heart valves
|
|
US20060204445A1
(en)
*
|
2005-03-11 |
2006-09-14 |
Anthony Atala |
Cell scaffold matrices with image contrast agents
|
|
CA2602029C
(en)
*
|
2005-03-11 |
2014-07-15 |
Wake Forest University Health Sciences |
Tissue engineered blood vessels
|
|
CN101252954A
(zh)
*
|
2005-06-30 |
2008-08-27 |
布里斯托尔-迈尔斯斯奎布药品公司 |
作为显像剂的酰肼偶联物
|
|
US9339559B2
(en)
|
2005-09-09 |
2016-05-17 |
Georgia State University Research Foundation, Inc. |
Targeted contrast agents and methods for targeting contrast agents
|
|
EP1745739A3
(en)
|
2005-07-14 |
2009-04-22 |
Bundesrepublik Deutschland, vertr. d.d. Bundes- ministerium f. Wirtschaft- und Technologie, dieses vertr. d.d. Präs. d. Phys.-Techn. Bundesanstalt |
Optical imaging of rheumatoid arthritis
|
|
US8034898B2
(en)
*
|
2005-12-29 |
2011-10-11 |
Collagen Medical, LLC |
Methods of collagen imaging
|
|
NZ583931A
(en)
|
2007-08-17 |
2012-06-29 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
WO2009054327A1
(ja)
*
|
2007-10-22 |
2009-04-30 |
Osaka Foundation For Trade And Industry |
Ｍｒｉ用プローブ
|
|
WO2010107832A1
(en)
|
2009-03-17 |
2010-09-23 |
Bracco Imaging Spa |
Lhrh-ii peptide analogs
|
|
WO2010121133A2
(en)
|
2009-04-17 |
2010-10-21 |
The General Hospital Corporation |
Multimodal imaging of fibrin
|
|
MX2011009716A
(es)
|
2009-03-19 |
2011-10-17 |
Wyeth Llc |
Metodos para la preparacion de acido [2-(8,9-dioxo)-2,6-diazabicic lo[5.2.0]non-1(7)-en-2-il)etil]fosfonico y precursores de este.
|
|
JP2011026294A
(ja)
|
2009-06-26 |
2011-02-10 |
Canon Inc |
化合物
|
|
WO2011035140A1
(en)
|
2009-09-18 |
2011-03-24 |
Paka Pulmonary Pharmaceuticals, Inc. |
Methods and compositions for delivery of contrast moieties to the lungs
|
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
CN102188722A
(zh)
*
|
2010-03-18 |
2011-09-21 |
中国科学院福建物质结构研究所 |
一种含二价铁的磁共振成像造影剂
|
|
US8192429B2
(en)
|
2010-06-29 |
2012-06-05 |
Theravant, Inc. |
Abnormality eradication through resonance
|
|
AU2012282678B2
(en)
|
2011-07-11 |
2016-03-03 |
California Institute Of Technology |
Akt-specific capture agents, compositions, and methods of using and making
|
|
WO2013131994A2
(en)
*
|
2012-03-08 |
2013-09-12 |
Thommen Medical Ag |
Coating for the diagnosis of inflammatory tissues in dental applications
|
|
WO2013131993A2
(en)
*
|
2012-03-08 |
2013-09-12 |
Thommen Medical Ag |
Device for the diagnosis of inflammatory tissues in dental applications
|
|
KR102575825B1
(ko)
|
2012-11-15 |
2023-09-06 |
엔도사이트, 인코포레이티드 |
Psma 발현 세포에 의해 야기되는 질병을 치료하기 위한 컨쥬게이트
|
|
SG11201602249RA
(en)
|
2013-10-18 |
2016-05-30 |
Deutsches Krebsforsch |
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
US10092679B2
(en)
|
2013-10-18 |
2018-10-09 |
Wake Forest University Health Sciences |
Laminous vascular constructs combining cell sheet engineering and electrospinning technologies
|
|
EA035171B1
(ru)
|
2013-11-14 |
2020-05-08 |
Эндосайт, Инк. |
Конъюгаты на основе связывающихся с psma лигандов или ингибиторов psma для позитронно-эмиссионной томографии
|
|
US20150344523A1
(en)
|
2014-05-05 |
2015-12-03 |
California Institute Of Technology |
Mutant akt-specific capture agents, compositions, and methods of using and making
|
|
US10471162B2
(en)
|
2014-06-20 |
2019-11-12 |
The General Hospital Corporation |
Collagen targeted imaging probes
|
|
US10188759B2
(en)
|
2015-01-07 |
2019-01-29 |
Endocyte, Inc. |
Conjugates for imaging
|
|
EP3270951B1
(en)
|
2015-03-16 |
2020-09-09 |
California Institute of Technology |
Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
|
|
EP3322716B1
(en)
|
2015-07-15 |
2025-02-12 |
California Institute of Technology |
Il-17f-specific capture agents and methods of using
|
|
CN115109120A
(zh)
|
2016-04-04 |
2022-09-27 |
英蒂分子公司 |
Cd8-特异性捕获剂、组合物及使用和制备方法
|
|
US11884707B2
(en)
|
2016-09-29 |
2024-01-30 |
Regeneron Pharmaceuticals, Inc. |
Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same
|
|
WO2018085375A1
(en)
|
2016-11-01 |
2018-05-11 |
Ohio State Innovation Foundation |
Methods for the iodination of biomolecules
|
|
WO2018200615A2
(en)
*
|
2017-04-27 |
2018-11-01 |
The Regents Of The University Of California |
Modified mri contrast agents and uses thereof
|
|
US11719705B2
(en)
|
2017-06-15 |
2023-08-08 |
Indi Molecular, Inc. |
IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making
|
|
WO2019075213A1
(en)
*
|
2017-10-11 |
2019-04-18 |
Northwestern University |
HEPARIN CONJUGATED TO PEPTIDES BINDING TO COLLAGEN FOR TARGETING BIOLOGICAL AND SYNTHETIC FABRICS
|
|
CN108314695B
(zh)
*
|
2018-01-04 |
2020-06-16 |
南京邮电大学 |
一种异种双核金属配合物的制备及应用
|
|
BR112020020961A2
(pt)
|
2018-04-17 |
2021-01-19 |
Endocyte, Inc. |
Métodos de tratamento de câncer
|
|
US11919972B2
(en)
|
2018-11-02 |
2024-03-05 |
Regeneron Pharmaceuticals, Inc. |
Peptide libraries with non-canonical amino acids
|
|
WO2020097531A1
(en)
|
2018-11-08 |
2020-05-14 |
Indi Molecular, Inc. |
Theranostic capture agents, compositions, and methods of using and making
|
|
WO2020186091A1
(en)
|
2019-03-12 |
2020-09-17 |
Indi Molecular, Inc. |
Cross-linked epitopes and methods of use thereof
|
|
US12201679B2
(en)
|
2019-04-05 |
2025-01-21 |
Institute For Systems Biology |
Epitope-targeted peptide immunostimulants
|
|
CN120097929A
(zh)
|
2019-05-20 |
2025-06-06 |
因多塞特股份有限公司 |
制备psma缀合物的方法
|
|
EP3972646A4
(en)
|
2019-05-20 |
2023-06-14 |
Ohio State Innovation Foundation |
Apohemoglobin-haptoglobin complexes and methods of using thereof
|
|
US12216122B2
(en)
|
2019-05-20 |
2025-02-04 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (IDO1)
|
|
US11414460B2
(en)
|
2019-07-19 |
2022-08-16 |
Institute For Systems Biology |
KRAS-specific capture agents, compositions, and methods of making and using
|
|
CN112891566A
(zh)
*
|
2019-12-04 |
2021-06-04 |
中国科学院宁波工业技术研究院慈溪生物医学工程研究所 |
一种纳米材料及其制备方法和包含其的造影剂
|
|
CN115996951A
(zh)
|
2020-04-30 |
2023-04-21 |
赛罗帕私人有限公司 |
抗cd103抗体
|
|
US12209142B2
(en)
|
2020-05-29 |
2025-01-28 |
Institute For Systems Biology |
SARS-CoV-2 epitope-targeted peptide immunostimulants
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
CN120093699B
(zh)
*
|
2025-03-06 |
2025-11-14 |
浙江大学 |
用于定位并稳定动脉粥样硬化斑块的诊疗分子、纳米粒及其制备方法
|